
Diane Nanstad recently joined Sanofi BioPharma as Vice President, Head, Health Systems Outcomes, U.S. Rare Disease. Before joining Sanofi, Diane worked as a Health Network Strategy Executive for Oracle Health. In her role at Oracle, she worked with provider organization clients on their organization’s strategic goals for quality, population health, and value-based care initiatives using Population Health Solutions, Analytics and data driven decisions.
Prior to Oracle she was a Program Director for Premier Applied Sciences at Premier Inc., providing real-world evidence data, analytics, prospective research, and clinical trial support for Life Science companies and provider organizations.
She was a Senior Product Manager in Corporate Accounts and Healthcare Solutions Marketing for Boston Scientific. In her role she worked with all eight divisions linking new and future products to value-based care provider goals.
At Boehringer Ingelheim Pharmaceuticals she owned the company’s portfolio responsibility in the Boston academic hospitals, then transitions to a District Sales Manager position covering Minnesota and North Dakota.
Diane has a BS in Psychology and Biology from Salem State University, and a BS in Retail Merchandising and Management from the University of Wisconsin Stout.
Diane has been an active member of the Women’s Health Leadership TRUST since 2012, and a member of the Board of Directors since 2019. She was recognized as the TRUST Mentor of the Year in 2022. She has served on the Membership and Forum Committees, was previously Co-Chair of the Programming and Sponsorship Committees, and is currently the Historian and Chair of the TRUST Archive Committee. She was a member of the Board of Directors for the ACHE-MN (American College of Health Care Executives, Minnesota Chapter) from 2016 to 2020 where she chaired the Events Committee and Annual Meeting